GSK Bulk Ingredient
NDC Database

GSK Bulk Ingredient

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Bulk Ingredient
  • Total Records 7
  • Latest Marketing Date 2025-12-16
  • Data Source FDA
  • First Marketing Date 2015-12-18
All
20
View
Bulk Ingredient
7
View
Drug for Further Processing
13
View
Company Overview

Company

GSK Bulk Ingredient

Country

United Kingdom

Email

Social Profiles

Company Snapshot

GSK Bulk Ingredient

980 Great West Road, Brentford, Middlesex TW8 9GS England

United Kingdom

www.gsk.com:443/en-gb/ View on Map
NDC Records ( 7 records )
2025
01 Jan
Bulk Ingredient NDC: 49401-000

Nonproprietary Name

belimumab

Dosage Form

LIQUID

Strength

1 kg/kg

Labeler

GlaxoSmithKline LLC

Marketing Category

BULK INGREDIENT

49401-000

Substance

BELIMUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2025-01-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2019
01 Jan
Bulk Ingredient NDC: 49401-012

Nonproprietary Name

mepolizumab

Dosage Form

LIQUID

Strength

1 kg/kg

Labeler

GlaxoSmithKline LLC

Marketing Category

BULK INGREDIENT

49401-012

Substance

MEPOLIZUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2019-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
09 Apr
Bulk Ingredient NDC: 49401-080

Nonproprietary Name

raxibacumab

Dosage Form

LIQUID

Strength

1 kg/kg

Labeler

GlaxoSmithKline LLC

Marketing Category

BULK INGREDIENT

49401-080

Substance

RAXIBACUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-04-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2015
18 Dec
Bulk Ingredient NDC: 58437-004

Nonproprietary Name

mepolizumab

Dosage Form

LIQUID

Strength

1 kg/kg

Labeler

GlaxoSmithKline LLC

Marketing Category

BULK INGREDIENT

58437-004

Substance

MEPOLIZUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2015-12-18

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2020
01 Jan
Bulk Ingredient NDC: 58437-009

Nonproprietary Name

mepolizumab

Dosage Form

LIQUID

Strength

1 kg/kg

Labeler

GlaxoSmithKline LLC

Marketing Category

BULK INGREDIENT

58437-009

Substance

MEPOLIZUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2020-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
16 Dec
Bulk Ingredient NDC: 58437-029

Nonproprietary Name

Depemokimab

Dosage Form

LIQUID

Strength

1 kg/kg

Labeler

GlaxoSmithKline LLC

Marketing Category

BULK INGREDIENT

58437-029

Substance

DEPEMOKIMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2025-12-16

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
23 Oct
Bulk Ingredient NDC: 12064-026

Nonproprietary Name

belantamab mafodotin

Dosage Form

LIQUID

Strength

1 kg/kg

Labeler

GlaxoSmithKline Manufacturing SpA

Marketing Category

BULK INGREDIENT

12064-026

Substance

BELANTAMAB MAFODOTIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2025-10-23

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    24 View
  • EDQM CEP
    23 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    20 View
  • FDA Approved Drugs Database
    377 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
7 total
  • Bulk Ingredient
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

49401-000

Nonproprietary Name

belimumab

Labeler

GlaxoSmithKline LLC

Dosage Form

LIQUID

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.